Tag: PPMI
The Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Progression Markers Initiative (PPMI), continues around the world.
Recent r...
The landmark Parkinson’s Progression Markers Initiative (PPMI) marches forward in its massive expansion, study leaders brought updates and ideas to ...
In the last six years, 16 new treatments have been improved for Parkinson’s but there is still much work to be done.
In this audio from our Thir...
The coronavirus pandemic has forced many research operations to go remote, including in our landmark Parkinson’s Progression Markers Initiative (PPM...
The landmark Parkinson’s Progression Markers Initiative (PPMI) study aims to better define and measure Parkinson’s disease so scientists can find ...
Two recent papers point to potential Parkinson’s biomarkers after analysis of data from The Michael J. Fox Foundation’s (MJFF) Parkinson’s Prog...
The Michael J. Fox Foundation (MJFF), the National Institutes of Health (NIH) and five life sciences companies today announced a public-private partn...
A new tool from researchers at Harvard Medical School may allow investigators to predict cognitive decline in people with Parkinson’s disease (PD), ...
No objective measurement — or biomarker — currently exists to diagnose Parkinson’s disease (PD). Instead, doctors must rely on a person’s me...
Principal investigator of the Parkinson’s Progression Markers Initiative (PPMI), Ken Marek, MD, presented the latest findings from the landmark bio...
Professor Dominic Rowe, the man at the center of some of the World’s best Parkinson’s research. Here’s what inspires him in his search for chang...
The first major study results from the Parkinson’s Progression Markers Initiative (PPMI) are highlighted in today’s edition of USA Today. The stu...
Sunday Night Australia taped exclusive interviews with friends of the Foundation last month, including Parkinson’s Progression Markers Initiative (P...